Avidity Science Expands Biomedical Research Solutions Through Acquisition of UMG, Inc.
August 3, 2021
WATERFORD, Wis. -- Today, Avidity Science announces another significant step in expanding its global leadership in biomedical research solutions via the acquisition of UMG, Inc. This investment expands Avidity's Radio Frequency Identification (RFID) solutions, enhancing its support of the global biomedical research community. "We are excited about this investment as it adds unique design, engineering and [...]
August 3, 2021
The Baker Company, global leader in containment technology, owner of Baker Ruskinn, itself a global leader in anaerobic and precision low-oxygen culture solutions for microbiology and cell culture applications, has signed a new partnership agreement with Scintica Instrumentation, Inc. Scintica will distribute exclusively Baker Ruskinn's anaerobic and physiological oxygen workstations along with revolutionary portable platforms [...]
August 3, 2021
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to help expand SARS-CoV-2 sequencing capabilities in the region and support the broader genomic surveillance effort across India. Kasturba Hospital was the first hospital in [...]
Partnership between Central Scientific Commerce and Cytosurge
August 3, 2021
Central Scientific Commerce, Inc. (CSC) and Cytosurge AG partner to distribute Cytosurge’s FluidFM OMNIUM system for unprecedented single cell research in the Japanese market Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within this partnership, CSC [...]
Abcam to acquire BioVision for $340 million
August 2, 2021
Cambridge, UK – Abcam plc (“Abcam”, “the Company” or “the Group”) (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that it has entered into a definitive agreement to acquire BioVision, Inc. (“BioVision”), a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. (“NKY”), for $340 million (the [...]
908 Devices Expands Scientific Advisory Board, Creates Dedicated Proteomics Panel
August 2, 2021
Company appoints six new members to SAB to maximize the company’s impact in the proteomics domain BOSTON -- 908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the forthcoming appointment of six new individuals to its Scientific Advisory Board (SAB), including Prof. Ileana Cristea, Prof. Jennifer E. Van Eyk, Prof. Anne-Claude [...]
August 2, 2021
TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human (FIH) phase 1 clinical trial in Thailand with mRNA manufacturing process development and its proprietary mRNA capping technology, ushering a much-needed vaccine into economically developing countries SAN DIEGO -- TriLink BioTechnologies (“TriLink”), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in [...]
SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer
August 2, 2021
NEW YORK & BOULDER, Colo. —CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, today announced the appointment of Shaun Blakeman as the company’s Chief Financial Officer. “We are thrilled to welcome Shaun Blakeman to the SomaLogic team,” said SomaLogic Chief Executive Officer Roy Smythe, M.D. “His depth of [...]
RIGAKU ACQUIRES LIFE SCIENCE IMAGING EQUIPMENT MANUFACTURER MILABS
August 2, 2021
Full-Scale Entry into the Global Life Sciences Business Rigaku Corporation (Headquarters: Akishima-shi, Tokyo; President: Toshiyuki Ikeda; "Rigaku"), a leading manufacturer of X-ray analysis equipment, has acquired all issued shares of MILabs B.V. (Headquarters: Houten, The Netherlands; CEO and CSO: Dr. Frederik Beekman; “MILabs”) on August 2, 2021, as part of their full-scale effort to enter [...]
August 2, 2021
HELSINKI, Finland -- Finnish bioinformatics software company Euformatics has been awarded funding through the Amazon Web Services (AWS) Diagnostic Development Initiative to deliver a revolutionary COVID-19 variant surveillance software tool. SYNLAB has agreed to be the first customer of the solution developed under the program. The funding also covers broader deployment of cloud-based tools around human [...]
